期刊文献+

NS-398对肝癌细胞SMMC-7721 COX-2、Survivin表达的影响

Effect of NS-398 on the expression of COX-2 and Survivin in hepatocellular car-cinoma SMMC-7721 cells
下载PDF
导出
摘要 目的:观察COX-2与Survivin在SMMC-7721细胞中的表达情况及COX-2抑制剂NS-398对二者表达的影响,探讨NS-398的抗肿瘤作用机制。方法:以不同浓度的NS-398(0、25、50、75、100、150μmol/L)处理SMMC-7721细胞24、48、72小时,应用qRT-PCR检测COX-2、Survivin mRNA的表达,应用Western blot检测COX-2、Survivin蛋白的表达,应用FCM鉴定COX-2、Survivin蛋白表达。结果:COX-2与Survivin在正常生长的SMMC-7721细胞中均有较高表达,NS-398处理后,COX-2、Survivin基因和蛋白表达均显著减少,即与NS-398的作用剂量及时间呈反比。结论:NS-398可能是通过降低COX-2与Survivin的表达来实现改变细胞周期、诱导凋亡,从而抑制肿瘤的生长。 Objective :To observe the expression of COX-2 and Survivin in hepatocellular carcinoma SMMC-7721 cells and in- vestigate the mechanism of NS-398 on inhibiting tumor cell growth. Methods: The hepatoma cell line SMMC-7721 was cultured and treated with different concentrations of NS-398. The expressions of COX-2 and Survivin mRNA were detected by RT-PCR method and the expressions of COX-2 and Survivin protein were detected by flow eytometry/finaneal capacity model(FCM) and Western blot method. Results: There was a high expression of COX-2 and Survivin gene/protein in SMMC-7721 cells. NS-398 inhibited the expression of COX-2 and Survivin expression in SMMC-7721 cells in the manner of dose and time dependent. Conclusion: NS-398 could inhibit proliferation and induce apoptosis of SMMC-7721 by inhibiting the expression of COX-2 and Survivin.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第12期1258-1261,共4页 Chinese Journal of Immunology
基金 吉林省科技厅基础研究项目(201015216) 重点实验室项目(20122113) 科技创新项目(20082102) 黑龙江省教育厅项目(11551509) 佳木斯大学项目(Sz2009-007)等项目的资助
关键词 SMMC-7721 环氧合酶-2 Survivin COX-2抑制剂NS-398 Hepatocellular carcinoma cell line Cyclooxygenase-2 Survivin COX-2 inhibitor NS-398
  • 相关文献

参考文献2

二级参考文献55

  • 1[1]Thun MJ,Namboodiri MM,Heath CW Jr.Aspirin use and reduced risk of fatal colon cancer.N Engl J Med 1991;325:1593-1596
  • 2[2]Giardiello FM,Hamilton SR,Krush AJ,Piantadosi S,Hylind LM,Celano P,Booker SV,Robinson CR,Offerhaus GJ.Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.N Engl J Med 1993;328:1313-1316
  • 3[3]Giardiello FM,Yang VW,Hylind LM,Krush AJ,Petersen GM,Trimbath JD,Piantadosi S,Garrett E,Geiman DE,Hubbard W,Offerhaus GJ,Hamilton SR.Primary chemoprevention of familial adenomatous polyposis with sulindac.N Engl J Med 2002;346:1054-1059
  • 4[4]Steinbach G,Lynch PM,Phillips RK,Wallace MH,Hawk E,Gordon GB,Wakabayashi N,Saunders B,Shen Y,Fujimura T,Su LK,Levin B.The effect of celecoxib,a cyclooxygenase-2 inhibitor,in familial adenomatous polyposis.N Engl J Med 2000;342:1946-1952
  • 5[5]Nugent KP,Farmer KC,Spigelman AD,Williams CB,Phillips RK.Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.Br J Surg 1993;80:1618-1619
  • 6[6]Labayle D,Fischer D,Vielh P,Drouhin F,Pariente A,Bories C,Duhamel O,Trousset M,Attali P.Sulindac causes regression of rectal polyps in familial adenomatous polyposis.Gastroenterology 1991;101:635-639
  • 7[7]Jacoby RF,Marshall DJ,Newton MA,Novakovic K,Tutsch K,Cole CE,Lubet RA,Kelloff GJ,Verma A,Moser AR,Dove WF.Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.Cancer Res 1996;56:710-714
  • 8[8]Beazer-Barclay Y,Levy DB,Moser AR,Dove WF,Hamilton SR,Vogelstein B,Kinzler KW.Sulindac suppresses tumorigenesis in the Min mouse.Carcinogenesis 1996;17:1757-1760
  • 9[9]Smith ML,Hawcroft G,Hull MA.The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells:evidence of different mechanisms of action.Eur J Cancer 2000;36:664-674
  • 10[10]Jones DA,Carlton DP,Mclntyre TM,Zimmerman GA,Prescott SM.Molecular cloning of human prostaglandin endoperoxide synthase type Ⅱ and demonstration of expression in response to cytokines.J Biol Chem 1993;268:9049-9054

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部